Home

Teladoc Health, Inc. Common Stock (TDOC)

8.2600
+0.3800 (4.82%)
NYSE · Last Trade: Jul 17th, 12:05 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close7.880
Open8.020
Bid8.250
Ask8.260
Day's Range7.965 - 8.350
52 Week Range6.350 - 15.21
Volume3,110,614
Market Cap1.35B
PE Ratio (TTM)-1.400
EPS (TTM)-5.9
Dividend & YieldN/A (N/A)
1 Month Average Volume8,797,690

Chart

About Teladoc Health, Inc. Common Stock (TDOC)

Teladoc Health is a leading telehealth company that provides virtual healthcare services, connecting patients with a wide range of healthcare professionals through digital platforms. The company offers various services, including remote consultations, mental health support, chronic condition management, and preventive care. By leveraging technology, Teladoc facilitates access to healthcare for individuals regardless of their location, aiming to improve health outcomes and enhance the patient experience. Their comprehensive solutions cater to both individual consumers and large employers, helping to make healthcare more accessible and efficient. Read More

News & Press Releases

Teladoc Health to Announce Second Quarter 2025 Financial Results
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second quarter 2025 results on Tuesday, July 29, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day.
By Teladoc Health, Inc. · Via GlobeNewswire · July 16, 2025
Unpacking Q1 Earnings: Teladoc (NYSE:TDOC) In The Context Of Other Online Marketplace Stocks
Looking back on online marketplace stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Teladoc (NYSE:TDOC) and its peers.
Via StockStory · July 15, 2025
Teladoc Health Launches Wellbound Employee Assistance Program (EAP)
New offering will support employee mental health and well-being across a broad spectrum of needs—from everyday work-life challenges to complex mental health conditions
By Teladoc Health, Inc. · Via GlobeNewswire · July 15, 2025
2 Momentum Stocks to Research Further and 1 to Be Wary Of
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to new product launches, positive news, or even a dedicated social media following.
Via StockStory · July 14, 2025
Zeta, Teladoc, Jamf, Dayforce, and 8x8 Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after a broader market sell-off triggered by renewed trade tensions. U.S. stock indices fell after the Trump administration announced intentions to impose a 35% tariff on many goods imported from Canada. 
Via StockStory · July 11, 2025
Teladoc (TDOC) Stock Trades Up, Here Is Why
Shares of digital medical services platform Teladoc Health (NYSE:TDOC) jumped 3.5% in the afternoon session after the company received a price target increase from an analyst at Evercore ISI Group. Evercore ISI analyst Elizabeth Anderson raised the firm's price target on the virtual healthcare company to $8.00 from $7.00, while maintaining an "In-Line" rating on the shares. 
Via StockStory · July 9, 2025
Multi-Billion Virtual Healthcare Industry Witnessing Substantial Growth with Rapid Expansion Expected
EQNX::TICKER_START (OTCQB:TREIF),(CSE:TRUE),(NYSE:CVS),(NYSE:TDOC),(NASDAQ:TEM),(NYSE:HIMS) EQNX::TICKER_END
Via FinancialNewsMedia · July 10, 2025
Demystifying Teladoc Health: Insights From 11 Analyst Reviewsbenzinga.com
Via Benzinga · July 9, 2025
Why Nektar Therapeutics Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · June 24, 2025
Multi-Billion Virtual Healthcare Industry Witnessing Substantial Growth with Rapid Expansion Expected
PALM BEACH, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The global telehealth market has been substantially growing over the past years and is expected to continue this growth well into the future. A report from Grand View Research said that: “The global telehealth market size was estimated at USD 123.26 billion in 2024 and is projected to reach USD 455.27 billion by 2030, growing at a CAGR of 24.68% from 2025 to 2030. North America dominated the telehealth market with the revenue share of 46.58% in 2024. The market is primarily driven by the increasing adoption of digital health & smartphones, rising investments, improved internet connectivity, and growing technological advancements… the growing adoption and acceptance of telehealth services are expected to boost the market's growth over the forecast period.” The report continued: “Moreover, smartphones have evolved from devices of communication & entertainment to devices that can monitor health and fitness. Some market players are developing Chatbot services for basic medical inquiries and one-time consultations… Moreover, the market is propelled by favorable government initiatives to expand telehealth by making healthcare services more accessible and convenient for patients. The focus on cost-effective and efficient healthcare solutions further propels the adoption of telehealth services. The rising adoption of telehealth facilities by patients, physicians, and government authorities is boosting the market. Access to healthcare through specific applications and video consultations enables communication between patients and doctors in remote locations, eliminating the need to visit hospitals or clinics. Market players such as Apple, Google, and IBM focus on improving the mobile health experience by providing numerous solutions through different subscription plans and emphasizing data security. These factors are expected to drive the market growth over the forecast period.”   Active tech companies in the markets this week include Treatment AI, Inc. (OTCQB: TREIF) (CSE: TRUE), CVS Health® (NYSE: CVS), Teladoc Health, Inc. (NYSE: TDOC), Tempus AI, Inc. (NASDAQ: TEM), Hims & Hers Health, Inc. (NYSE: HIMS).
By FN Media Group LLC · Via GlobeNewswire · July 10, 2025
Teladoc (TDOC) Stock Trades Up, Here Is Why
Shares of digital medical services platform Teladoc Health (NYSE:TDOC) jumped 10.9% in the afternoon session after Citron Research published a report highlighting the company's growth potential following Teladoc's impressive updates at a Goldman Sachs Healthcare conference. 
Via StockStory · June 23, 2025
Teladoc Health Stock Jumps After Citron Research Calls It A 'Coiled Spring'benzinga.com
Teladoc Health Inc (NYSE:TDOC) shares are rising Monday after Citron Research made positive comments about the company on its X account.
Via Benzinga · June 23, 2025
3 Cash-Producing Stocks in the Doghouse
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via StockStory · June 18, 2025
3 Small-Cap Stocks in Hot Water
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Via StockStory · June 13, 2025
3 Internet Stocks in the Doghouse
Whether it be online shopping or social media, secular forces are propelling consumer internet businesses forward. These themes have enabled rapid growth for the industry, which has posted a 1.4% gain over the past six months. This was a good place to be as the S&P 500 was flat.
Via StockStory · June 9, 2025
DraftKings, Teladoc, Rush Street Interactive, Moderna, and Avis Budget Group Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as the Bureau of Labor Statistics report revealed a resilient labor market with non-farm payrolls rising by 139,000 in May 2025, significantly above the consensus forecast of 125,000. 
Via StockStory · June 6, 2025
Teladoc Health to Participate in Upcoming Investor Conference
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Goldman Sachs 46th Annual Global Healthcare Conference in Miami on Wednesday, June 11th, 2025, at 9:20 a.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations.
By Teladoc Health, Inc. · Via GlobeNewswire · June 5, 2025
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to two new employees.
By Teladoc Health, Inc. · Via GlobeNewswire · June 3, 2025
3 of Wall Street’s Favorite Stocks Walking a Fine Line
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Via StockStory · June 2, 2025
Deep Dive Into Teladoc Health Stock: Analyst Perspectives (11 Ratings)benzinga.com
Via Benzinga · May 27, 2025
1 Russell 2000 Stock for Long-Term Investors and 2 to Be Wary Of
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
Via StockStory · May 23, 2025
Cogent, C3.ai, Teladoc, and Camping World Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the major indices pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that could worsen the already wide US fiscal deficit. 
Via StockStory · May 21, 2025
Teladoc's Outlook Clouds As JPMorgan Points To Uncertainty In Behavioral Health, Margin Pressurebenzinga.com
JP Morgan analyst Lisa C. Gill maintained Neutral rating on TDOC with $9 price target, down from $11. Teladoc reports Q1 revenue of $629.4M.
Via Benzinga · May 16, 2025
1 Beaten-Down Stock to Buy Right Now, and 1 to Avoidfool.com
Via The Motley Fool · May 16, 2025
TDOC Q1 Earnings Call: UpLift Acquisition and Integrated Care Growth Shape Teladoc’s Outlook
Digital medical services platform Teladoc Health (NYSE:TDOC) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 2.6% year on year to $629.4 million. The company expects next quarter’s revenue to be around $623.5 million, close to analysts’ estimates. Its non-GAAP loss of $0.01 per share was 96.5% above analysts’ consensus estimates.
Via StockStory · May 14, 2025